Faculty

Institution

Unit

Venue

William H. Morrison

Professor Associate Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Radiation Oncology

Department Of Experimental Radiation Oncology

Department Of Head And Neck Surgery

Department Of Head And Neck Surgery, Section Of Speech Pathology And Audiology

Division Of Radiation Oncology

The University of Texas MD Anderson Cancer Center

William H. Morrison is a Professor of Radiation Oncology at The University of Texas MD Anderson Cancer Center. His research focuses on radiation oncology, with specific interests in proton versus photon radiotherapy for oropharyngeal cancer, radiation biology, and the epidemiology of treatment-related toxicities. He has led a multicentre, randomised phase 3 trial comparing proton and photon therapy, published in *The Lancet*, and developed externally validated digital decision-support tools for osteoradionecrosis risk stratification. His recent work also includes neoadjuvant immunotherapy for cutaneous squamous cell carcinoma of the head and neck and carotid artery volumetry changes following unilateral radiation therapy.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

William H. Morrison

The University of Texas MD Anderson Cancer Center

Professor Associate Professor

You can click a keyword to filter the displayed items

radiation oncology oncology radiation therapy radiation cancer treatment neck oncology cancer research epidemiology clinical radiation oncology medicine radiology surgical oncology cancer care radiation biology proton therapy oral pathology outcomes research cancer imaging medical imaging cancer biology oropharyngeal cancer cancer management thoracic oncology nuclear medicine oral cancer neuro-oncology larynx neck cancer anatomical pathology neurosurgery skin cancer clinical trials thyroid clinical otolaryngology neck pathology long-term outcomes surgical pathology gynecologic oncology computed tomography dosimetry respiratory medicine melanoma viral oncology skull base brachytherapy otorhinolaryngology patient-reported outcomes oncologic imaging intensity-modulated radiotherapy medicinal research jama oncology radiation exposure intensity-modulated radiation therapy nasopharyngeal carcinoma head-and-neck cancer definitive radiotherapy advanced laryngeal cancer clinical outcomes cancer letter malignant disease radiation therapy planning adaptive radiotherapy thyroid disease retrospective cohort studies cohort studies intensity-modulated photon therapy postoperative radiotherapy intensity-modulated proton therapy vascular biology endocrine oncology neck disorder positron emission tomography postoperative radiation therapy squamous cell carcinomas uveal melanoma dermatopathology metastasis nuclear chemistry cosmetic dermatology prostate cancer medical physics breast cancer oral radiology dermatology gynecologic cancers integrative medicine

Notable Scholarly Works

Notable Federal Grants

Collaborators

Recurrent Maxillary Ameloblastoma Presenting as an External Auditory Canal Mass. The Laryngoscope (2026)

neurotologyotorhinolaryngologyclinical otolaryngologyoral pathology

1659P Updated Pathologic Responses From a Pilot Phase II Trial of Neoadjuvant Immunotherapy for Stage II-IV Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck (Cscc-Hn). Annals of Oncology (2025)

cancer immunotherapypathologypathologic responsesoncologysurgical oncologyneck oncologyneoadjuvant immunotherapycellular therapyimmunotherapydermatologyimmune checkpoint inhibitorsskin cancer

Designing an Electronic Patient-Reported Outcomes Information Infrastructure Supported by the Re-Aim Implementation Framework. Advances in Cancer Education and Quality Improvement (2025)

digital healthhealth information scienceoutcomes researchhealth informaticshealth policyhealth technologydigital medicinemedical information systemse-health serviceelectronic health recordshealth systemsehealthnursinghealth information systemsimplementation researchre-aim implementation frameworkhealth services research

Detection of Alteration in Carotid Artery Volumetry Using Standard-Of-Care Computed Tomography Surveillance Scans Following Unilateral Radiation Therapy for Early-Stage Tonsillar Squamous Cell Carcinoma Survivors: A Cross-Sectional Internally-Matched Carotid Isodose Analysis. Clinical and Translational Radiation Oncology (2025)

Efstratios KoutroumpakisMohamed A NaserAbdallah Sherif Radwan MohamedSalman A ErajAndrea JarreJay C ShiaoMona KamalSubha PerniJack P PhanWilliam H MorrisonSteven J FrankG Brandon GunnAdam S GardenAnita DeswalJun-Ichi AbeDavid I RosenthalElie MouhayarClifton D Fuller

cancer imagingmedicineneuroradiologyoncologysurvival analysisradiation oncologyradiation detectionradiationmedical imagingimage analysisbiomedical imagingcomputed tomographyradiation therapyradiologyoncologic imagingpartially ordered setcarotid artery volumetryunilateral radiation therapy

Externally Validated Digital Decision Support Tool for Time-To-Osteoradionecrosis Risk-Stratification Using Right-Censored Multi-Institutional Observational Cohorts. Radiotherapy and Oncology (2025)

Laia Humbert-VidanSerageldin KamelAndrew WentzelZaphanlene KaffeyMoamen AbdelaalKyle B SpierNatalie A WestG Elisabeta MaraiGuadalupe CanahuateXinhua ZhangMelissa M ChenKareem A WahidJillian RigertSeyedmohammadhossein HosseinianAndrew J SchaeferKristy K BrockMark ChambersAdegbenga O OtunRuth Aponte-WessonVinod PatelAndrew HopeJack PhanAdam S GardenSteven J FrankWilliam H MorrisonMichael T SpiottoDavid RosenthalAnna LeeRenjie HeMohamed A NaserErin WatsonKatherine A HutchesonAbdallah S R MohamedVlad C SandulacheLisanne V van DijkAmy C MorenoTeresa Guerrero UrbanoClifton D FullerStephen Y Lai

digital healthpublic healthtime-to-osteoradionecrosis risk-stratificationcohort studies

Phase III Trial of Proton Versus Photon Radiotherapy for Oropharyngeal Cancer. SSRN Electronic Journal (2025)

oropharyngeal cancerproton therapyoncologysurgical oncologyradiation oncologyradiationneck oncologyradiation therapyphase iii trialradiologynuclear medicine

Proton Versus Photon Radiotherapy for Patients With Oropharyngeal Cancer in the USA: A Multicentre, Randomised, Open-Label, Non-Inferiority Phase 3 Trial. The Lancet (2025)

oropharyngeal cancerclinical trialsproton therapycancer imagingmedicinephoton radiotherapyoncologyoral cancerradiation oncologyneck oncologyradiationradiation therapynon-inferiority phase 3cancer carenuclear medicine

Association Between Locoregional Failure and Nfe2L2/Keap1/Cul3 Mutations in Nrg/Rtog 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer. Clinical Cancer Research (2024)

Li GuanPedro A. Torres-SaavedraXiaobei ZhaoMichael B. MajorBrittany J. HolmesNgan K. NguyenParasakthy KumaraveluTim HodgeMaximilian DiehnJose P. ZevallosF. Christopher HolsingerBahman EmamiRichard C. JordanMichele C. HaywardStephen M. SagarWilliam MorrisonChristopher SchultzJimmy J. CaudellChristopher U. JonesScott V. BratmanThomas J. GallowayDaniel J. MaSue S. YomMahesh KudrimotiHarold E. KimJonathan HarrisQuynh-Thu LeD. Neil. Hayes

clinical trialscancer researchoncologyrandomized triallocoregional failuremolecular biologycancer geneticsclinical researchradiation fractionationclinical investigation

Clinical Acceptability of Automatically Generated Lymph Node Levels and Structures of Deglutition and Mastication for Head and Neck Radiation Therapy. Physics and Imaging in Radiation Oncology (2024)

Sean MaroongrogeAbdallah Sr MohamedCallistus NguyenJean Guma De la VegaSteven J FrankAdam S GardenBrandon G GunnAnna LeeLauren MayoAmy MorenoWilliam H MorrisonJack PhanMichael T SpiottoLaurence E CourtClifton D FullerDavid I RosenthalTucker J Netherton

medical imaginglymph node levelsclinical acceptabilityradiation oncology

Mandibular Dose-Volume Predicts Time-To-Osteoradionecrosis in an Actuarial Normal-Tissue Complication Probability (Ntcp) Model: External Validation of Right-Censored Clinico-Dosimetric and Competing Risk Application Across International Multi-Institutional Observational Cohorts and Online Graphical User Interface Clinical Support Tool Assessment. medRxiv (2024)

Laia Humbert-VidanSerageldin KamelAndrew WentzelZaphanlene KaffeyMoamen AbdelaalKyle B. SpierNatalie A. WestG. Elisabeta MaraiGuadalupe CanahuateXinhua ZhangMelissa M. ChenKareem A. WahidJillian RigertSeyedmohammadhossein HosseinianAndrew J. SchaeferKristy K. BrockMark ChambersAdegbenga O. OtunRuth Aponte-WessonVinod PatelAndrew HopeJack PhanAdam S. GardenSteven J. FrankWilliam H MorrisonMichael T SpiottoDavid RosenthalAnna LeeRenjie HeMohamed A. NaserErin WatsonKatherine A. HutchesonAbdallah S. R. MohamedVlad C. SandulacheLisanne V. van DijkAmy C. MorenoTeresa Guerrero UrbanoStephen Y. LaiClifton D. Fuller

critical caredosimetryrisk applicationactuarial scienceexternal validation

1
2
3
4
5
37
10 / page

William H. Morrison

Professor Associate Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Radiation Oncology

Department Of Experimental Radiation Oncology

Department Of Head And Neck Surgery

Department Of Head And Neck Surgery, Section Of Speech Pathology And Audiology

Division Of Radiation Oncology

The University of Texas MD Anderson Cancer Center

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

William H. Morrison

The University of Texas MD Anderson Cancer Center

Professor Associate Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Recurrent Maxillary Ameloblastoma Presenting as an External Auditory Canal Mass. The Laryngoscope (2026)

neurotologyotorhinolaryngologyclinical otolaryngologyoral pathology

cancer immunotherapypathologypathologic responsesoncologysurgical oncologyneck oncologyneoadjuvant immunotherapycellular therapyimmunotherapydermatologyimmune checkpoint inhibitorsskin cancer

Designing an Electronic Patient-Reported Outcomes Information Infrastructure Supported by the Re-Aim Implementation Framework. Advances in Cancer Education and Quality Improvement (2025)

digital healthpublic healthtime-to-osteoradionecrosis risk-stratificationcohort studies

Phase III Trial of Proton Versus Photon Radiotherapy for Oropharyngeal Cancer. SSRN Electronic Journal (2025)

oropharyngeal cancerproton therapyoncologysurgical oncologyradiation oncologyradiationneck oncologyradiation therapyphase iii trialradiologynuclear medicine

Proton Versus Photon Radiotherapy for Patients With Oropharyngeal Cancer in the USA: A Multicentre, Randomised, Open-Label, Non-Inferiority Phase 3 Trial. The Lancet (2025)

Association Between Locoregional Failure and Nfe2L2/Keap1/Cul3 Mutations in Nrg/Rtog 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer. Clinical Cancer Research (2024)

clinical trialscancer researchoncologyrandomized triallocoregional failuremolecular biologycancer geneticsclinical researchradiation fractionationclinical investigation

medical imaginglymph node levelsclinical acceptabilityradiation oncology

critical caredosimetryrisk applicationactuarial scienceexternal validation

1
2
3
4
5
37
10 / page